Linda Rubinstein

2018 - Five Prime Therapeutics

In 2018, Linda Rubinstein earned a total compensation of $530.2K as Former Interim Chief Financial Officer at Five Prime Therapeutics.

Compensation breakdown

Salary$530,171
Total$530,171

Rubinstein received $530.2K in salary, accounting for 100% of the total pay in 2018.

Rankings

In 2018, Linda Rubinstein's compensation ranked 11,677th out of 14,244 executives tracked by ExecPay. In other words, Rubinstein earned more than 18.0% of executives.

ClassificationRankingPercentile
All
11,677
out of 14,244
18th
Division
Manufacturing
4,712
out of 5,765
18th
Major group
Chemicals And Allied Products
1,783
out of 2,128
16th
Industry group
Drugs
1,518
out of 1,817
17th
Industry
Pharmaceutical Preparations
1,166
out of 1,391
16th

Pay ratio

Linda Rubinstein's Pay$530,171
Median Employee's Pay$201,670
Pay Ratio

3

to 1

In 2018, the annual total compensation of Linda Rubinstein was $530,171.

The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.

The ratio of Linda Rubinstein's pay to the pay of median employee was therefore 3 to one.

Source: SEC filing on April 29, 2019.

Rubinstein's colleagues

We found six more compensation records of executives who worked with Linda Rubinstein at Five Prime Therapeutics in 2018.

2018

Aron Knickerbocker

Five Prime Therapeutics

Chief Executive Officer

2018

David Smith

Five Prime Therapeutics

Chief Financial Officer

2018

Bryan Irving

Five Prime Therapeutics

Chief Scientific Officer

2018

Helen Collins

Five Prime Therapeutics

Chief Medical Officer

2018

Francis Sarena

Five Prime Therapeutics

Secretary

2018

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

News

You may also like